Aptamers as Biomarkers for Neurological Disorders. Proof of Concept in Transgenic Mice Blood-based diagnostics provide a minimally invasive way to detect molecular changes associated with disease. In this study, we used aptamers as biomarkers to…
NeoNeuro Partners with the INSIGHT Cohort NeoNeuro SAS has entered into a collaboration under the leadership of Professor Harald Hampel to work with the INSIGHT cohort for the application of the Aptamarker Platform to pre-AD samples.…
NeoNeuro Collaborates with the AIBL Study NeoNeuro SAS is pleased to announce a collaboration with the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) group. The collaboration is focused on exploring the potential…
NeoNeuro Awarded a New BPI France Grant NeoNeuro recently received a new grant from BPI France to advance research on developing aptamers as diagnostic and therapeutic tools for Alzheimer’s disease. This funding enables our team…
NeoNeuro Receives BPI France Grant NeoNeuro has received support from BPI France under the PIA-1 program to advance the use of aptamers as diagnostic and therapeutic tools for Alzheimer’s disease. This funding allows our team…
